시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 수면제 시장 보고서(2025년)
Sleeping Pills Global Market Report 2025
상품코드 : 1769755
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,448,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,320,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,193,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 수면제 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 예측 기간 동안 예상되는 주요 동향으로는 커스터마이즈된 수면 치료를 위한 디지털 바이오마커의 이용, AI와 머신러닝의 응용, 칸나비노이드 기반의 치료의 진보, 나노테크를 이용한 약물전달, 수면 추적을 위한 웨어러블 디바이스 등이 있습니다.

정신질환의 유병률 증가는 향후 수년간 수면제 시장의 확대를 촉진할 것으로 예측됩니다. 수면제는 감정이나 인지의 안정을 유지하기 위해 필수적인 수면의 질을 높임으로써 정신건강 문제의 관리에 중요한 역할을 하고 있습니다. 2022년 National Institute of Mental Health는 미국의 18세 이상의 성인 5,930만 명이 어떠한 정신질환(AMI)과 함께 생활하고 있으며, 이는 성인 인구의 23.1%에 상당한다고 보고했습니다.

수면제 시장에서 사업을 전개하는 기업은 수면의 질을 개선하고, 의존 가능성을 줄이고, 부작용을 최소화하기 위한 신흥국 제제의 개발에 점점 힘을 쏟고 있습니다. 흡수성 개선, 부작용 감소, 보다 적은 환자 친화적인 치료제 제공을 목적으로 하는 새로운 약제 조성물의 창출을 수반합니다. 2024년 10월, Neurovalens는 22세 이상 성인의 만성 불면증 치료용으로 FDA 인가를 받은 의사 처방의 의료기기, Modius Sleep을 발표했습니다. 통상 취침 1-2시간 전, 저녁에 30분간 머리에 장착하고 편안함을 유지하기 위해 강도를 조절할 수 있는 것이 특징으로, 독서나 TV 감상 등의 여가 활동 중에도 사용할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

JHS
영문 목차

영문목차

Sleeping pills, also referred to as sedative-hypnotics, are drugs designed to aid individuals in initiating or maintaining sleep. These medications are frequently prescribed for the short-term management of insomnia or other related sleep disorders. By depressing the central nervous system, sleeping pills help induce drowsiness and encourage restful sleep.

There are two primary categories of sleeping pills: prescription and over-the-counter (OTC) options. These substances, which include a range of product types such as benzodiazepines and non-benzodiazepines, are intended to assist individuals in falling asleep, staying asleep, or enhancing overall sleep quality. They are used in the treatment of various conditions like insomnia, sleep apnea, restless leg syndrome, narcolepsy, and sleepwalking. Consumer demand for these products differs based on demographics such as age, gender, and health status. They are distributed through several channels, including retail pharmacies, online platforms, hospitals and clinics, as well as health and wellness outlets.

The sleeping pills market research report is one of a series of new reports from The Business Research Company that provides sleeping pills market statistics, including sleeping pills industry global market size, regional shares, competitors with a sleeping pills market share, sleeping pills market segments, market trends and opportunities, and any further data you may need to thrive in the sleeping pills industry. This sleeping pills market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sleeping pills market size has grown strongly in recent years. It will grow from $79.21 billion in 2024 to $85.87 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. Growth during the historical period was supported by heightened awareness of sleep health, rising stress and anxiety levels, lifestyle shifts due to urbanization, a growing elderly population, and increased R&D efforts.

The sleeping pills market size is expected to see strong growth in the next few years. It will grow to $117.31 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. This projected growth is driven by the rising preference for non-addictive solutions, innovations in personalized and targeted sleep therapies, enhanced investments in biotechnology, stricter regulatory pathways, and the expansion of healthcare systems. Key trends anticipated during the forecast period include the use of digital biomarkers for customized sleep treatments, AI and machine learning applications, progress in cannabinoid-based therapies, nanotech-enabled drug delivery, and wearable devices for sleep tracking.

The growing prevalence of mental illness is anticipated to drive the expansion of the sleeping pills market in the coming years. Mental illness encompasses a broad range of conditions that influence mood, cognition, behavior, and overall functioning. The rise in mental illness cases is largely attributed to increasing levels of chronic stress, which can impair brain function and exacerbate mental health disorders. Sleeping pills play a significant role in managing mental health issues by enhancing sleep quality, which is vital for maintaining emotional and cognitive stability. These medications help alleviate symptoms of anxiety and depression by promoting restful sleep and supporting improved mental health and daily functioning. For example, in 2022, the National Institute of Mental Health reported that 59.3 million adults aged 18 and older in the United States were living with any mental illness (AMI), representing 23.1% of the adult population. As a result, the rising prevalence of mental illness is a key driver behind the growing demand for sleeping pills.

Companies operating in the sleeping pills market are increasingly focused on developing advanced formulations to improve sleep quality, reduce dependency potential, and minimize side effects. These advanced formulations involve creating new medication compositions aimed at enhancing effectiveness, improving absorption, reducing adverse effects, and offering more targeted, patient-friendly treatments. For example, in October 2024, UK-based medical device company Neurovalens introduced Modius Sleep, a physician-prescribed medical device cleared by the FDA for treating chronic insomnia in adults aged 22 and older. This device uses low-level electrical vestibular nerve stimulation to influence the hypothalamus and brainstem-key areas responsible for regulating sleep and circadian rhythms. Worn on the head for 30 minutes in the evening, typically 1-2 hours before bedtime, the device features adjustable intensity for comfort and can be used during leisure activities such as reading or watching television.

In October 2023, Apnimed, a pharmaceutical company based in the United States, entered a joint venture with Shionogi & Co. Ltd. to develop new pharmacologic treatments for obstructive sleep apnea and other sleep-related disorders. The collaboration focuses on innovative oral treatment solutions. Shionogi & Co. Ltd., headquartered in Japan, specializes in the development of advanced sleeping pills and oral therapies for sleep disorders.

Major players in the sleeping pills market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Eisai Co Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Cipla Limited, Aurobindo Pharma Ltd. , Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Mallinckrodt Pharmaceuticals plc, Idorsia Pharmaceuticals Ltd, Procter & Gamble Health Limited (P&G Health), Allegiant Health.

Norh America was the largest region in the sleeping pills market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in sleeping pills report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sleeping pills market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sleeping pills market consists of sales of over-the-counter antihistamines, melatonin supplements, and herbal or natural sleep remedies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sleeping Pills Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sleeping pills market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for sleeping pills ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sleeping pills market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Sleeping Pills Market Characteristics

3. Sleeping Pills Market Trends And Strategies

4. Sleeping Pills Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sleeping Pills Growth Analysis And Strategic Analysis Framework

6. Sleeping Pills Market Segmentation

7. Sleeping Pills Market Regional And Country Analysis

8. Asia-Pacific Sleeping Pills Market

9. China Sleeping Pills Market

10. India Sleeping Pills Market

11. Japan Sleeping Pills Market

12. Australia Sleeping Pills Market

13. Indonesia Sleeping Pills Market

14. South Korea Sleeping Pills Market

15. Western Europe Sleeping Pills Market

16. UK Sleeping Pills Market

17. Germany Sleeping Pills Market

18. France Sleeping Pills Market

19. Italy Sleeping Pills Market

20. Spain Sleeping Pills Market

21. Eastern Europe Sleeping Pills Market

22. Russia Sleeping Pills Market

23. North America Sleeping Pills Market

24. USA Sleeping Pills Market

25. Canada Sleeping Pills Market

26. South America Sleeping Pills Market

27. Brazil Sleeping Pills Market

28. Middle East Sleeping Pills Market

29. Africa Sleeping Pills Market

30. Sleeping Pills Market Competitive Landscape And Company Profiles

31. Sleeping Pills Market Other Major And Innovative Companies

32. Global Sleeping Pills Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sleeping Pills Market

34. Recent Developments In The Sleeping Pills Market

35. Sleeping Pills Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기